Target intelligence / Profile preview

Nucleophosmin 1 pseudogene 19 (NPM1P19)

Target
NPM1P19
Molecular classification
Other
01

Overview

Nucleophosmin 1 pseudogene 19 (NPM1P19) is a non-coding pseudogene related to the NPM1 gene, which encodes nucleophosmin, a multifunctional chaperone protein involved in ribosome biogenesis, cell proliferation, and cancer biology[1][3]. Pseudogenes like NPM1P19 share sequence similarity with their parent genes but lack coding potential due to mutations or deletions and are typically biologically inactive. Unlike NPM1, which plays well-established roles in cancer—particularly acute myeloid leukemia—NPM1P19 has no known biological function, disease association, or role as a drug target. Key clarifications: - NPM1P19 is not a receptor, enzyme, transporter, channel, or signaling protein. It is a pseudogene, which generally do not produce functional proteins or serve as drug targets. - Information about NPM1 (not NPM1P19) includes critical roles in cancer prognosis, transcriptional regulation, and its use as a biomarker in acute myeloid leukemia[1][3]. However, these properties do not apply to pseudogenes such as NPM1P19. Summary for later structured extraction: NPM1P19 is a pseudogene with no established therapeutic, biological, or disease-related role, and is not a real molecular target for drugs or biomarker development. Any references connecting it with disease or function are likely erroneous or due to mistaking it for its parent gene, NPM1.

Other names
NPM1P19
02

Mechanism of action

None

03

Biological functions

None established; as a pseudogene, NPM1P19 does not encode a protein or have a defined biological function. No evidence of regulatory activity or functional RNA product described in literature or database curation.
04

Disease associations

None established; there are no direct disease associations or biomarker roles for NPM1P19. Any disease relationship would be speculative and not supported by data.

Beyond the preview

Go deeper on Nucleophosmin 1 pseudogene 19 (NPM1P19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophosmin 1 pseudogene 19 (NPM1P19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call